Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke

Stroke

Volumn 41, Issue 2, 2010, Pages 343-349

  Shimotake, Janet ^a   Derugin, Nikita ^a   Wendland, Michael ^b   Vexler, Zinaida S ^a   Ferriero, Donna M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Apoptosis; Cerebral ischemia; Development; Necrosis; Postnatal

Indexed keywords

CALPAIN; CASPASE 3; DIMETHYL SULFOXIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN; PROTEIN IBA 1; SEMAXANIB; SPECTRIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; INDOLE DERIVATIVE; PYRROLE DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; CAUDATE NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ENDOTHELIUM CELL; GLIA CELL; GLIOSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STROKE; TISSUE REPAIR; ANIMAL; BRAIN ARTERY; CEREBRAL ARTERY DISEASE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NECROSIS; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CALPAIN; CASPASE 3; CELL PROLIFERATION; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; INDOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77449131068     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.564229     Document Type: Article

References (24)

1. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke Workshop on Perinatal and Childhood Stroke. Pediatrics. 2002;109:116-123.
2. Derugin N, Wendland M, Muramatsu K, Roberts T, Gregory G, Ferriero D, Vexler Z. Evolution of brain injury after transient middle céré bral artery occlusion in neonatal rat. Stroke. 2000;31:1752-1761.
3. Mu D, Jiang X, Sheldon RA, Fox CK, Hamrick SE, Vexler ZS, Ferriero DM. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis. 2003;14:524-534.
4. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, Levinson AD. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest. 1993;91:160-170.
5. Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res. 2000;119:139-153.
6. Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001;106:148-156.
7. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cérébral ischemia. J Clin Invest. 2003;111:1843-1851.
8. Kuo CT, Mirzadeh Z, Soriano-Navarro M, Rasin M, Wang D, Shen J, Sestan N, Garcia-Verdugo J, Alvarez-Buylla A, Jan LY, Jan YN. Postnatal deletion of numb/numblike reveals repair and remodeling capacity in the subventricular neurogenic niche. Cell. 2006;127: 1253-1264.
9. Skold MK, Risling M, Holmin S. Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. Eur J Neurosci. 2006;23:21-34.
10. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106:829-838.
11. Laudenbach V, Fontaine RH, Medja F, Carmeliet P, Hicklin DJ, Gallego J, Leroux P, Marret S, Gressens P. Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis. 2007;26: 243-252.
12. Feng Y, Rhodes PG, Bhatt AJ. Neuroprotective effects of vascular en-dothelial growth factor following hypoxic ischemic brain injury in neonatal rats. Pediatr Res. 2008;64:370-374.
13. Derugin N, Dingman A, Wendland M, Fox C, Vexler ZS. Magnetic resonance imaging as a surrogate measure for histological sub-chronic endpoint in a neonatal rat stroke model. Brain Res. 2005;1066:49-56.
14. Wendland MF, Faustino J, West T, Manabat C, Holtzman DM, Vexler ZS. Early diffusion-weighted MRI as a predictor of caspase-3 activation following hypoxic-ischemic insult in neonatal rodents. Stroke. 2008;39: 1862-1868.
15. Manabat C, Han BH, Wendland M, Derugin N, Fox CK, Choi J, Holtzman DM, Ferriero DM, Vexler ZS. Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain. Stroke. 2003;34:207-213.
16. Portera-Cailliau C, Price DL, Martin LJ. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol. 1997;378:70-87.
17. Phillis JW, Estevez AY, O'Regan MH. Protective effects of the free radical scavengers, dimethyl sulfoxide and ethanol, in cérébral ischemia in gerbils. Neurosci Lett. 1998;244:109-111.
18. Bao WL, Lu SD, Wang H, Sun FY. Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cérébral ischemia. Zhongguo Yao Li Xue Bao. 1999;20:313-318.
19. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-439.
20. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci. 2000;12:4243-4254.
21. Silverman WF, Krum JM, Mani N, Rosenstein JM. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience. 1999;90:1529-1541.
22. Jin K, Mao XO, Batteur SP, McEachron E, Leahy A, Greenberg DA. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience. 2001;108:351-358.
23. Svensson B, Peters M, Konig HG, Poppe M, Levkau B, Rothermundt M, Arolt V, Kogel D, Prehn JH. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexci-totoxic, caspase-independent mechanism. J Cereb Blood Flow Metab. 2002;22:1170-1175.
24. Wang L, Chopp M, Gregg SR, Zhang RL, Teng H, Jiang A, Feng Y, Zhang ZG. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab. 2008;28: 1361-1368.